Page last updated: 2024-11-04

suramin and Leishmaniasis, Visceral

suramin has been researched along with Leishmaniasis, Visceral in 2 studies

Suramin: A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. (From AMA Drug Evaluations Annual, 1992, p1643) It has also been shown to have potent antineoplastic properties.
suramin : A member of the class of phenylureas that is urea in which each of the amino groups has been substituted by a 3-({2-methyl-5-[(4,6,8-trisulfo-1-naphthyl)carbamoyl]phenyl}carbamoyl)phenyl group. An activator of both the rabbit skeletal muscle RyR1 and sheep cardiac RyR2 isoform ryanodine receptor channels, it has been used for the treatment of human African trypanosomiasis for over 100 years.

Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Khanra, S1
Juin, SK1
Jawed, JJ1
Ghosh, S1
Dutta, S1
Nabi, SA1
Dash, J1
Dasgupta, D1
Majumdar, S1
Banerjee, R1
TELLA, A1

Other Studies

2 other studies available for suramin and Leishmaniasis, Visceral

ArticleYear
In vivo experiments demonstrate the potent antileishmanial efficacy of repurposed suramin in visceral leishmaniasis.
    PLoS neglected tropical diseases, 2020, Volume: 14, Issue:8

    Topics: Animals; Antiprotozoal Agents; Apoptosis; Cytokines; Disease Models, Animal; Dose-Response Relations

2020
CHEMOTHERAPY OF TROPICAL DISEASES.
    Current medicine and drugs, 1964, Volume: 4, Issue:10

    Topics: Amebiasis; Amebicides; Anti-Bacterial Agents; Antimalarials; Antimony; Arsenicals; Chagas Disease; C

1964